Recently, LAG3 expression was previously found to be significantly higher in CD8+ tumor-infiltrating helper T cells and CD8+ cytotoxic T cells than in tumor-free liver tissue and blood from patients with hepatocellular carcinoma (37). Here, LAG3 is linked to hepatocellular carcinoma.